Health tech’s role in obesity to expand beyond a ‘nice-to-have’
In recent years, there has been a sharp focus on treating obesity and its associated comorbidities, as the World Health…
05 Aug 2026
Orexin receptor agonists set to propel narcolepsy treatment into a new era
Note: A few hours after this article was published, oveporexton was approved as a treatment for narcolepsy type 1. More details can be found here. A decision on the highly…
31 Jul 2026
Boosting CGT access: a global consideration with wide-spanning benefits
Back in 2014, Jonathan Clark’s world was flipped on its head when he was diagnosed with mantle cell lymphoma (MCL) at age 52. While Clark began receiving treatment soon after…
27 Jul 2026
Magazine: Made in the USA
A combination of US government incentives, supply chain disruptions, and geopolitical tensions are prompting increased investment in US manufacturing. In this month's cover story, we spoke to Misumi Americas CEO…
21 Jul 2026
AAIC26: Alzheimer’s disease heterogeneity calls for a rethink
The Alzheimer’s space has surpassed several key milestones over the past few years, with the first disease-modifying therapies (DMTs) and blood-based biomarker tests securing the regulatory green light and offering…
13 Jul 2026
Podcast: Patient advocates join the blood cancer ASCT vs CAR-T debate
In recent years, there has been strong discourse in the blood cancer space around the best way to treat patients as the industry’s focus sharpens on keeping a patient’s cancer…
07 Jul 2026
Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive
Following multibillion dollar asset acquisitions and artificial intelligence (AI)-centred deals, Servier’s head of business development outlines how one of France’s leading pharma companies is planning for the future amidst a…